share_log

JD Health's Risk-Reward Ratio Looks Appealing -- Market Talk

JD Health's Risk-Reward Ratio Looks Appealing -- Market Talk

JD Health的风险回报比看起来很有吸引力--市场讨论
Dow Jones Newswires ·  2021/05/23 22:19

DJ JD Health's Risk-Reward Ratio Looks Appealing -- Market Talk

DJ JD Health的风险回报比看起来很有吸引力--市场言论

0219 GMT - JD Health International's risk-reward ratio seems attractive, as the share price has plunged in recent months, Daiwa Capital says. It upgrades the stock to outperform from hold and lowers the target price to HK$130.50 from HK$148.20. The investment bank raises its 2021-22 revenue forecast for the company by 5%-7% as it expects JD Health to record fast user-traffic growth, thanks to the strength of its digital marketing segment, which posted triple-digit growth in 2020. JD Health's consistent track record in online healthcare services and its supply-chain infrastructure could be profit-growth drivers, Daiwa adds. Shares are down 7.2% at HK$109.90 amid a broader selloff in Hong Kong tech shares. (yiwei.wong@wsj.com)

0219GMT-大和资本表示,JD Health International的风险回报比似乎很有吸引力,因为该公司股价近几个月来大幅下跌。它将该股评级从持有上调至跑赢大盘,并将目标价从148.20港元下调至130.50港元。这家投资银行将该公司2021-22年的收入预期上调了5%-7%,因为它预计JD Health将录得快速的用户流量增长,这要归功于其数字营销部门的强劲表现,该部门在2020年实现了三位数的增长。大和补充称,JD Health在在线医疗服务及其供应链基础设施方面的一贯记录可能是利润增长的驱动力。在香港科技股普遍抛售的背景下,该公司股价下跌7.2%,至109.90港元。(yi wei.wong@wsj.com)

(END) Dow Jones Newswires

(完)道琼通讯社

May 23, 2021 22:19 ET (02:19 GMT)

2021年5月23日22:19美国东部时间(格林尼治标准时间02:19)

Copyright (c) 2021 Dow Jones & Company, Inc.

版权所有(C)2021年道琼斯公司

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发